Dermapharm SE Laborant bedient Maschine

Dermapharm off to an excellent start to financial year 2022

Dermapharm Holding SE ("Dermapharm"), a rapidly growing manufacturer of branded pharmaceuticals, increased its consolidated revenue by 9.1% to EUR 231.6 million in the first quarter of financial year 2022 (prior-year period: EUR 212.2 million).

Dermapharm - Pharmaceutical Excellence “Made in Germany”

Dermapharm is a rapidly growing manufacturer of branded pharmaceuticals. Founded in 1991, the Company is based in Grünwald near Munich. The Company's integrated business model comprises in-house development, production and the distribution of brand products by a trained pharmaceutical sales force. In addition to its main location in Brehna near Leipzig, Dermapharm also operates other production, development and distribution locations in Europe (primarily in Germany) and the United States.

Read Annual Report 2021

Dermapharm SE Arbeit im Labor
Dermapharm SE Icon Glasflasche

PHARMACEUTICAL INGREDIENTS

>380

Dermapharm SE Icon Bündel Geldscheine

REVENUE 2021

EUR 942.9 million

Dermapharm SE Icon Stift und Papier

MARKETING AUTHORISATIONS

∼1,300

Dermapharm SE Icon steigender Aktienkurs

EBITDA 2021 
(unadjusted)

EUR 354.4 million

Reasons to invest

  1. Clear focus on Germany as a production location
  2. Rapidly growing pharmaceutical manufacturer in selected niche markets
  3. Own R&D with about 40 ongoing development projects in the pipeline
  4. Successful track record in acquisitions
  5. Increasing expansion of international presence

To Factsheet 3M 2022

Dermapharm SE Icon Glasflasche

PHARMACEUTICAL INGREDIENTS

>380

Dermapharm SE Icon Stift und Papier

MARKETING AUTHORISATIONS

∼1,300

Dermapharm SE Icon Bündel Geldscheine

REVENUE 2021

EUR 942.9 million

Dermapharm SE Icon steigender Aktienkurs

EBITDA 2021 
(unadjusted)

EUR 354.4 million

Share

Financial Reports & Presentations

Recent Publications

Our brands and location

Find your way to our subsidiaries at different locations worldwide on a clearly arranged map!

Dermapharm SE Weltausschnitt Europa

IR Newsletter Service

We will be happy to include you in our news service!
Please fill out the form and you will receive information on investor relations topics.

Dermapharm SE News Tablet

Sustainability within the Dermapharm Group

Are you interested in sustainability? So are we! Read the details in our CSR report or find information on our investment in energy-efficient buildings or the resource-conserving use of raw materials directly under the highlights.

 

Dermapharm SE Photovoltaikanlage im Sonnenuntergang